Tag:
Kadmon I LLC
Latest Headlines
Latest Headlines
Waksal inks pair of hepatitis C pacts for his start-up
Sam Waksal ( photo ) got a chance to flex his long neglected deal-making muscles with a pair of pacts with Valeant Pharmaceuticals ( $VRX ) that will help the ex-con build up a hepatitis C franchise as
Waksal making big development plans for his new biotech venture
Whatever else anyone had to say about Sam Waksal ( photo )--and there was always plenty--he had few peers when it comes to touting the prospects of a biotech company. Now with his five-year prison
Waksal back to deal-making mode, snags Three Rivers for $100M
The Wall Street Journal broke the story this morning that Sam Waksal's Kadmon Pharmaceuticals has struck a deal to buy Three Rivers Pharmaceuticals for $100 million as he promises to take what he
Waksal's back, raising $50M for new biotech venture
Here's a scoop: TheStreet's Adam Feuerstein reports that the disgraced former ImClone CEO Sam Waksal has hatched a plan to raise $50 million for a new biotech company that would acquire, develop or
